Silvana Saavedra

552 total citations
23 papers, 180 citations indexed

About

Silvana Saavedra is a scholar working on Hematology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silvana Saavedra has authored 23 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silvana Saavedra's work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (7 papers) and Polyomavirus and related diseases (6 papers). Silvana Saavedra is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Acute Myeloid Leukemia Research (7 papers) and Polyomavirus and related diseases (6 papers). Silvana Saavedra collaborates with scholars based in Spain and Chile. Silvana Saavedra's co-authors include Miguel Á. Sanz, Rodrigo Martino, Javier de la Rubia, Luís Larrea, Leonor Senent, Jorge Sierra, Isidro Jarque, Jesús Martı́nez, Federico Moscardó and Irene García‐Cadenas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Cancers.

In The Last Decade

Silvana Saavedra

20 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvana Saavedra Spain 6 154 55 47 42 32 23 180
Bhuvan Kishore United Kingdom 8 158 1.0× 83 1.5× 23 0.5× 48 1.1× 12 0.4× 39 240
Wan-Jun Sun China 7 158 1.0× 61 1.1× 40 0.9× 61 1.5× 31 1.0× 23 211
Clémence Mediavilla France 8 88 0.6× 31 0.6× 31 0.7× 26 0.6× 15 0.5× 18 137
David Loach Canada 12 297 1.9× 87 1.6× 83 1.8× 62 1.5× 84 2.6× 28 350
Mauricio Sarmiento Chile 8 78 0.5× 29 0.5× 24 0.5× 29 0.7× 20 0.6× 23 146
Giancarlo Fatobene Brazil 7 96 0.6× 42 0.8× 20 0.4× 37 0.9× 37 1.2× 22 185
Lisa Murray United States 7 96 0.6× 19 0.3× 76 1.6× 31 0.7× 45 1.4× 12 195
Luisa Sisinni Spain 9 110 0.7× 79 1.4× 20 0.4× 66 1.6× 48 1.5× 27 201
Damianos Sotiropoulos Greece 8 92 0.6× 46 0.8× 27 0.6× 37 0.9× 50 1.6× 28 172
Jérémy Delage France 8 143 0.9× 63 1.1× 21 0.4× 25 0.6× 63 2.0× 12 195

Countries citing papers authored by Silvana Saavedra

Since Specialization
Citations

This map shows the geographic impact of Silvana Saavedra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Saavedra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Saavedra more than expected).

Fields of papers citing papers by Silvana Saavedra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Saavedra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Saavedra. The network helps show where Silvana Saavedra may publish in the future.

Co-authorship network of co-authors of Silvana Saavedra

This figure shows the co-authorship network connecting the top 25 collaborators of Silvana Saavedra. A scholar is included among the top collaborators of Silvana Saavedra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvana Saavedra. Silvana Saavedra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Cadenas, Irene, Albert Esquirol, Silvana Saavedra, et al.. (2025). Standard Versus Reduced‐Doses of Post‐Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation. European Journal Of Haematology. 115(4). 413–422.
2.
3.
Saavedra, Silvana, et al.. (2024). Enfermedades reumatológicas y compromiso pulmonar, lo que hay que saber. SHILAP Revista de lepidopterología. 35(3-4). 262–272.
4.
Saavedra, Silvana, et al.. (2024). Gastric dysrhythmias in patients with early systemic sclerosis: a cross-sectional study. Rheumatology Advances in Practice. 8(2). rkae041–rkae041.
5.
García‐Cadenas, Irene, Silvana Novelli, Silvana Saavedra, et al.. (2023). Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature. Transplantation and Cellular Therapy. 29(7). 473.e1–473.e6. 5 indexed citations
6.
Esquirol, Albert, Irene García‐Cadenas, Silvana Novelli, et al.. (2023). Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience. Annals of Hematology. 103(1). 321–334. 1 indexed citations
7.
García‐Cadenas, Irene, Albert Esquirol, Silvana Novelli, et al.. (2023). Evolution in the frontline treatment of patients with chronic lymphocytic leukemia: experience from one European center. Leukemia & lymphoma. 64(10). 1655–1661. 1 indexed citations
8.
García‐Cadenas, Irene, Antonio Vila, Albert Esquirol, et al.. (2023). Sequence matters: Total body irradiation (TBI)‐based myeloablative conditioning with post‐transplant cyclophosphamide may reduce the early nonrelapse mortality compared with pretransplant cyclophosphamide plus TBI. European Journal Of Haematology. 111(1). 146–153. 2 indexed citations
9.
Hernández‐Boluda, Juan Carlos, Alberto Álvarez‐Larrán, José María Raya, et al.. (2022). Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis. Cancers. 14(9). 2331–2331. 3 indexed citations
10.
Fox, María Laura, Irene García‐Cadenas, Ariadna Pérez, et al.. (2020). Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis. Leukemia & lymphoma. 61(8). 1823–1832. 2 indexed citations
11.
García‐Cadenas, Irene, Silvana Novelli, Silvana Saavedra, et al.. (2020). Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching. Bone Marrow Transplantation. 56(4). 818–827. 26 indexed citations
12.
13.
14.
15.
Castro, Ariel, H Gatica, Pilar Carrasco‐Garrido, et al.. (2019). AB0325 PREVALENCE OF ANXIETY/DEPRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS AT THE UNIVERSITY OF CHILE'S CLINICAL HOSPITAL AND THEIR ASSOCIATIONS WITH DISSEASE ACTIVITY INDEXES AND QUALITY OF LIFE. Annals of the Rheumatic Diseases. 78. 1620–1621. 1 indexed citations
16.
Cuéllar‐García, Carolina, Salut Brunet, Javier Briones, et al.. (2018). Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy. Clinical Lymphoma Myeloma & Leukemia. 18(11). 737–742. 2 indexed citations
17.
García‐Cadenas, Irene, David Valcárcel, Rodrigo Martino, et al.. (2012). Updated Experience with Inolimomab as Treatment for Corticosteroid-Refractory Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 19(3). 435–439. 8 indexed citations
18.
Sanz, Jaime, Pau Montesinos, Silvana Saavedra, et al.. (2010). Single-Unit Umbilical Cord Blood Transplantation from Unrelated Donors in Adult Patients with Chronic Myelogenous Leukemia. Biology of Blood and Marrow Transplantation. 16(11). 1589–1595. 24 indexed citations
19.
Sanz, Jaime, Miguel Á. Sanz, Silvana Saavedra, et al.. (2009). Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 16(1). 86–94. 64 indexed citations
20.
Rubia, Javier de la, Guillermo Martı́n, Jesús Martı́nez, et al.. (2001). Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia. Leukemia Research. 25(8). 685–692. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhuvan Kishore Breakdown of academic impact, for papers by Wan-Jun Sun Breakdown of academic impact, for papers by Clémence Mediavilla Breakdown of academic impact, for papers by David Loach Breakdown of academic impact, for papers by Mauricio Sarmiento Breakdown of academic impact, for papers by Giancarlo Fatobene Breakdown of academic impact, for papers by Lisa Murray Breakdown of academic impact, for papers by Luisa Sisinni Breakdown of academic impact, for papers by Damianos Sotiropoulos Breakdown of academic impact, for papers by Jérémy Delage
Rankless by CCL
2026